Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis. Issue 6 (11th April 2015)
- Record Type:
- Journal Article
- Title:
- Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis. Issue 6 (11th April 2015)
- Main Title:
- Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis
- Authors:
- Lee, Hongsik
Jeong, Hyeyeun
Park, Sangeun
Yoo, Wonbaek
Choi, Soyoung
Choi, Kyungmin
Lee, Min‐Goo
Lee, Mihwa
Cha, DaeRyong
Kim, Young‐Sik
Han, Jeeyoung
Kim, Wonkon
Park, Sun‐Hwa
Oh, Junseo - Abstract:
- <abstract abstract-type="main" id="emmm201404527-abs-0001"> <title>Abstract</title> <p>Activated hepatic stellate cells (HSCs) play a key role in liver fibrosis, and inactivating HSCs has been considered a promising therapeutic approach. We previously showed that albumin and its derivative designed for stellate cell‐targeting, retinol‐binding protein–albumin domain III fusion protein (referred to as R‐III), inactivate cultured HSCs. Here, we investigated the mechanism of action of albumin/R‐III in HSCs and examined the anti‐fibrotic potential of R‐III <italic>in vivo</italic>. R‐III treatment and albumin expression downregulated retinoic acid (RA) signaling which was involved in HSC activation. RA receptor agonist and retinaldehyde dehydrogenase overexpression abolished the anti‐fibrotic effect of R‐III and albumin, respectively. R‐III uptake into cultured HSCs was significantly decreased by siRNA‐STRA6, and injected R‐III was localized predominantly in HSCs in liver. Importantly, R‐III administration reduced CCl<sub>4</sub>‐ and bile duct ligation‐induced liver fibrosis. R‐III also exhibited a preventive effect against CCl<sub>4</sub>‐inducd liver fibrosis. These findings suggest that the anti‐fibrotic effect of albumin/R‐III is, at least in part, mediated by downregulation of RA signaling and that R‐III is a good candidate as a novel anti‐fibrotic drug.</p> </abstract>
- Is Part Of:
- EMBO molecular medicine. Volume 7:Issue 6(2015:Jun.)
- Journal:
- EMBO molecular medicine
- Issue:
- Volume 7:Issue 6(2015:Jun.)
- Issue Display:
- Volume 7, Issue 6 (2015)
- Year:
- 2015
- Volume:
- 7
- Issue:
- 6
- Issue Sort Value:
- 2015-0007-0006-0000
- Page Start:
- 819
- Page End:
- 830
- Publication Date:
- 2015-04-11
- Subjects:
- Molecular biology -- Periodicals
Medical genetics -- Periodicals
Pathology, Molecular -- Periodicals
616.04205 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1757-4684 ↗
http://www3.interscience.wiley.com/journal/120756871/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.15252/emmm.201404527 ↗
- Languages:
- English
- ISSNs:
- 1757-4676
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3582.xml